Xencor | Passività Correnti



Current Liabilities Cambiamento Data
AbbVie USD 36.4B 2.35B 2025-03
Alnylam Pharmaceuticals USD 1.3B 225.22M 2025-06
Amgen USD 23.01B 91M 2025-03
Arrowhead Research USD 220.54M 126.78M 2025-03
AstraZeneca USD 33.54B 4.41B 2025-06
Biogen USD 3.18B 2.11B 2025-06
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Cytokinetics USD 159.73M 19.95M 2025-03
GlaxoSmithKline GBP 20.38B 453M 2025-06
J&J USD 56.9B 6.58B 2025-03
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 25.17B 3.25B 2025-03
Novartis USD 31.71B 95M 2025-06
Pfizer USD 36.45B 6.54B 2025-03
Regeneron Pharmaceuticals USD 3.57B 2.13B 2025-03
Roche Holding CHF 27.02B 424M 2024-12
Xencor USD 88.44M 1M 2025-03


Xencor Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.